JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB283378

HDAC Inhibitor Drug Screening Kit (Fluorometric)

Be the first to review this product! Submit a review

|

(2 Publications)

Inhibition of histone deacetylase (HDAC) has been implicated to modulate transcription, to induce apoptosis or differentiation in cancer cells.

Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.

View Alternative Names

RPD3L1, HDAC1, Histone deacetylase 1, HD1, Protein deacetylase HDAC1, Protein deacylase HDAC1

1 Images
Functional Studies - HDAC Inhibitor Drug Screening Kit (Fluorometric) (AB283378)
  • FuncS

Supplier Data

Functional Studies - HDAC Inhibitor Drug Screening Kit (Fluorometric) (AB283378)

Key facts

Detection method

Fluorescent

Sample types

Inhibitor compounds

Assay Platform

Microplate (12 x 8 well strips)

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Inhibition of histone deacetylase (HDAC) has been implicated to modulate transcription, to induce apoptosis or differentiation in cancer cells. However, screening of compounds for HDAC inhibition has been difficult due to the lack of convenient tools for analyzing HDAC activity. The new HDAC Inhibitor Drug Screening Kit provides a fast, fluorescence-based method that eliminates radioactivity, extractions, or chromatography, as used in traditional assays. The new procedure requires only two easy steps, both performed on the same microtiter plate. First, your inhibitor candidates are mixed with HeLa Nuclear Extract and HDAC fluorometric substrate, which comprises an acetylated lysine side chain. Deacetylation of the substrate sensitizes the substrate, so that, in the second step, treatment with the Lysine Developer produces a fluorophore. The fluorophore can be easily analyzed using a fluorescence plate reader or a fluorometer. The assay is well suited for high throughput screening applications.

This product is manufactured by BioVision, an Abcam company and was previously called K340 HDAC Inhibitor Drug Screening Kit (Fluorometric). K340-100 is the same size as the 100 test size of ab283378.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab283378-100Test", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"HeLa Nuclear Extract", "number":"AB283378-CMP04", "productcode":"" }, { "size":"1 x 1 mL", "name":"Developer Mix M", "number":"AB283378-CMP05", "productcode":"" }, { "size":"1 x 500 µL", "name":"HDAC Substrate", "number":"AB283378-CMP03", "productcode":"" }, { "size":"1 x 10 µL", "name":"HDAC Inhibitor", "number":"AB283378-CMP02", "productcode":"" }, { "size":"1 x 1 mL", "name":"10X Assay Buffer 30", "number":"AB283378-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Histone deacetylases commonly known as HDACs are enzymes that remove acetyl groups from histone proteins resulting in chromatin tightening and reduced gene transcription. These enzymes fall into several classes each with distinct structural features and typically have molecular masses ranging from 41 to 70 kDa. HDACs are expressed in various tissues including brain heart and muscle. HDAC activity is essential for the regulation of many cellular processes and can be measured using assays such as the HDAC activity assay or the colorimetric assay.
Biological function summary

HDACs play an important role in gene expression through the remodeling of chromatin structure. They are often part of multiprotein complexes with co-repressor proteins helping modulate the transcription of genes involved in cell cycle regulation and differentiation. This modulation impacts cellular activities such as proliferation and apoptosis making HDACs significant in normal cellular function and development. HDAC inhibitors serve as tools for research in studying HDAC functions and as potential therapeutic agents.

Pathways

HDACs influence the regulation of important cellular pathways like the cell cycle and apoptosis. They interact with other proteins such as histone deacetylase inhibitor proteins and transcription factors to regulate gene expression tightly. In the cell cycle pathway HDACs can repress the transcription of cyclin-dependent kinase inhibitors therefore promoting cell cycle progression. Their involvement in the apoptosis pathway is also important where they regulate pro-apoptotic and anti-apoptotic gene expression contributing to cellular homeostasis.

HDACs have a significant connection to cancer and neurological disorders. Overexpression or dysregulation of HDACs can lead to tumorigenesis by affecting cell cycle checkpoints and apoptotic pathways. HDAC inhibitors have been investigated as potential cancer therapies targeting cellular proliferation and survival mechanisms. In neurological disorders HDACs are associated with neurodegenerative diseases due to their role in neuronal gene expression regulation. Proteins such as the tumor suppressor p53 in cancer and tau proteins in Alzheimer's disease have connections to HDAC function linking these enzymes to pathological processes.

Product protocols

Target data

Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed : 16762839, PubMed : 17704056, PubMed : 28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed : 16762839, PubMed : 17704056). Histone deacetylases act via the formation of large multiprotein complexes (PubMed : 16762839, PubMed : 17704056). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed : 16428440, PubMed : 28977666). As part of the SIN3B complex is recruited downstream of the constitutively active genes transcriptional start sites through interaction with histones and mitigates histone acetylation and RNA polymerase II progression within transcribed regions contributing to the regulation of transcription (PubMed : 21041482). Also functions as a deacetylase for non-histone targets, such as NR1D2, RELA, SP1, SP3, STAT3 and TSHZ3 (PubMed : 12837748, PubMed : 16285960, PubMed : 16478997, PubMed : 17996965, PubMed : 19343227). Deacetylates SP proteins, SP1 and SP3, and regulates their function (PubMed : 12837748, PubMed : 16478997). Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons (PubMed : 19081374). Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation (PubMed : 19081374). Deacetylates TSHZ3 and regulates its transcriptional repressor activity (PubMed : 19343227). Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B (PubMed : 17000776). Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity (PubMed : 17996965). Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development (By similarity). Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator : CLOCK-BMAL1 heterodimer (By similarity). Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation (By similarity). In addition to protein deacetylase activity, also has protein-lysine deacylase activity : acts as a protein decrotonylase and delactylase by mediating decrotonylation ((2E)-butenoyl) and delactylation (lactoyl) of histones, respectively (PubMed : 28497810, PubMed : 35044827).
See full target information HDAC1

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

ACS central science 11:346-356 PubMed40028358

2025

Bayesian Optimization over Multiple Experimental Fidelities Accelerates Automated Discovery of Drug Molecules.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew A McDonald,Brent A Koscher,Richard B Canty,Jason Zhang,Angelina Ning,Klavs F Jensen

Journal of biochemical and molecular toxicology 38:e70079 PubMed39620426

2024

Synthesis, Biological Evaluation and in Silico Studies of Novel Urea/Thiourea Derivatives of Lenalidomide.

Applications

Unspecified application

Species

Unspecified reactive species

Fatih Tok,Burçin İrem Abas,Faika Başoğlu,Özge Çevik,Sevgi Karakuş,Abdulilah Ece
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com